[{"_path":"/blog/5_benefits_of_checklists_in_clinical_trial_startup","_dir":"blog","_draft":false,"_partial":false,"_locale":"","title":"5 Benefits of Using a Comprehensive Checklist for Clinical Trial Start-up","description":"In the dynamic field of clinical trials, ensuring an efficient start-up phase is critical to the success of your research. One emerging best practice involves utilizing a comprehensive checklist during the clinical trial start-up. This approach, famously used by ClinicalPURSUIT, minimizes delays and overcomes typical setbacks by streamlining the process and optimizing coordination among all stakeholders.","_type":"markdown","_id":"content:blog:5_benefits_of_checklists_in_clinical_trial_startup.md","_source":"content","_file":"blog/5_benefits_of_checklists_in_clinical_trial_startup.md","_stem":"blog/5_benefits_of_checklists_in_clinical_trial_startup","_extension":"md","sitemap":{"loc":"/blog/5_benefits_of_checklists_in_clinical_trial_startup"}},{"_path":"/blog/5-key-challenges-biopharmaceutical-development-overcome","_dir":"blog","_draft":false,"_partial":false,"_locale":"","title":"5 Key Challenges in Biopharmaceutical Development and How to Overcome Them","description":"Biopharmaceutical development is a complex, multi-faceted process that often encounters several challenges before a product can be brought to market. The intricacies involved in developing biopharmaceutical medications—from monoclonal antibodies to other biologics—demand not only advanced scientific understanding but also strategic foresight to navigate potential roadblocks efficiently. This article explores five key challenges faced by industry professionals and provides practical solutions to overcome these hurdles.","_type":"markdown","_id":"content:blog:5-key-challenges-biopharmaceutical-development-overcome.md","_source":"content","_file":"blog/5-key-challenges-biopharmaceutical-development-overcome.md","_stem":"blog/5-key-challenges-biopharmaceutical-development-overcome","_extension":"md","sitemap":{"loc":"/blog/5-key-challenges-biopharmaceutical-development-overcome"}}]